Product ID: 160918
Reminder: The pictures are all real shots on this site and are for reference only; if there may be a delay in the launch of new packaging, please refer to the actual product.
Venetoclax is part of a group of drugs known as B-cell lymphoma-2 (BCL-2) inhibitors. It blocks the activity of a particular protein found in the body, which assists cancer cells in surviving.
India Direct Mail
Venetoclax is administered as a single drug or together with Obinutuzumab (Gazyva) or Rituximab (Rituxan) in order to manage specific kinds of chronic lymphocyticleukemia (CLL, a kind of cancer that starts within the white blood cells) or specific types of small lymphocytic cancer (SLL or a kind of cancer that starts within the lymph nodes). It is also utilized together with either azacitidine (Vidaza) or decitabine (Dacogen) or cytarabine for the initial treatment for acute myeloid lymphoma (AML which is a form of cancer that starts with white blood cells) for patients who are over the age of 75 or more, or in patients with medical conditions that hinder treatment with other chemotherapy drugs.